IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,068,965 | -28.9% | 1,993,179 | +10.0% | 0.00% | 0.0% |
Q2 2023 | $12,758,234 | +61.1% | 1,812,249 | +39.9% | 0.00% | 0.0% |
Q1 2023 | $7,917,307 | -20.6% | 1,295,795 | -17.0% | 0.00% | 0.0% |
Q4 2022 | $9,972,566 | -34.1% | 1,560,652 | -1.2% | 0.00% | -33.3% |
Q3 2022 | $15,135,000 | -14.2% | 1,579,942 | -1.1% | 0.00% | -25.0% |
Q2 2022 | $17,632,000 | +77.2% | 1,597,097 | +167.2% | 0.00% | +100.0% |
Q1 2022 | $9,952,000 | -14.2% | 597,687 | -1.6% | 0.00% | 0.0% |
Q4 2021 | $11,597,000 | -24.4% | 607,502 | -2.4% | 0.00% | -33.3% |
Q3 2021 | $15,344,000 | -10.6% | 622,214 | -5.7% | 0.00% | 0.0% |
Q2 2021 | $17,166,000 | -19.8% | 659,706 | -2.4% | 0.00% | -25.0% |
Q1 2021 | $21,392,000 | -31.5% | 675,709 | +0.3% | 0.00% | -33.3% |
Q4 2020 | $31,245,000 | +39.3% | 673,399 | -1.1% | 0.01% | +20.0% |
Q3 2020 | $22,423,000 | +17.7% | 681,180 | -1.8% | 0.01% | 0.0% |
Q2 2020 | $19,048,000 | -56.9% | 693,911 | -53.0% | 0.01% | -61.5% |
Q1 2020 | $44,231,000 | +9.5% | 1,477,540 | +1.3% | 0.01% | +44.4% |
Q4 2019 | $40,390,000 | +50.0% | 1,459,215 | -1.4% | 0.01% | +50.0% |
Q3 2019 | $26,929,000 | -21.1% | 1,479,616 | +6.3% | 0.01% | -25.0% |
Q2 2019 | $34,122,000 | +159.7% | 1,391,601 | +0.7% | 0.01% | +166.7% |
Q1 2019 | $13,139,000 | +9.5% | 1,381,691 | +1.9% | 0.00% | 0.0% |
Q4 2018 | $12,004,000 | -0.0% | 1,356,387 | +27.1% | 0.00% | 0.0% |
Q3 2018 | $12,007,000 | -7.9% | 1,067,296 | +4.7% | 0.00% | 0.0% |
Q2 2018 | $13,043,000 | -11.5% | 1,018,949 | +16.9% | 0.00% | -25.0% |
Q1 2018 | $14,736,000 | +151.9% | 871,985 | +19.2% | 0.00% | +300.0% |
Q4 2017 | $5,850,000 | +16.3% | 731,289 | +12.7% | 0.00% | 0.0% |
Q3 2017 | $5,031,000 | +126.2% | 648,995 | +114.5% | 0.00% | 0.0% |
Q2 2017 | $2,224,000 | – | 302,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |